EUVIMEDEUVIMED entdecken
Crossref

Prospects and therapeutic strategies in the management of dry eye disease: a review

Irina A. Fedorova, Andrey V. Zolotarev, Olga A. Kiseleva, Elena V. Karlova

Ophthalmology Reports · 30.06.2026 · 19 (2) · 83-93

DOI: 10.17816/ov696065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmology Reports, online erschienen am 30.06.2026. Verfasst von Irina A. Fedorova und 3 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dry eye disease (DED) is a widespread multifactorial disease, which makes the search for new effective therapies highly relevant. The novelty of this review lies in the comprehensive examination of the pathogenesis of DED and the substantiation of a promising treatment direction using corneal extracellular matrix biomimetics. The analysis showed that modern therapy of DED is not limited to simple lubrication and should be aimed at restoring ocular surface homeostasis and breaking the vicious cycle of chronic inflammation. Furthermore, it was found that multi-component preparations based on extracellular matrix biomimetics, in particular SFERO® Oko (BIOMIR Service JSC, Russia), demonstrate high efficacy in stimulating corneal regeneration and are promising for inclusion in therapeutic regimens for dry eye disease. Special attention is paid to drugs approved by the U.S. Food and Drug Administration, including cyclosporine; Xiidra® (lifitegrast 5%, Bausch Lomb Inc., USA)[℘]; Eysuvis® (loteprednol etabonate 0.25%, Kala Pharmaceuticals, USA)[℘]; Miebo® (perfluorohexyloctane, Novaliq, Germany)[℘]; and Tyrvaya® (varenicline nasal spray, Oyster Point Pharma Inc., USA)[℘]. This scientific review is based on an analysis of Russian and international sources from 2015 to 2025 and is intended for practicing ophthalmologists seeking a personalized approach to dry eye disease treatment. [℘] A drug is not registered in the Russian Federation.

Zitieren

APA

Fedorova, I. A., Zolotarev, A. V., Kiseleva, O. A., & Karlova, E. V. (2026). Prospects and therapeutic strategies in the management of dry eye disease: a review. Ophthalmology Reports, 19(2), 83-93. https://doi.org/10.17816/ov696065

Vancouver

Fedorova IA, Zolotarev AV, Kiseleva OA, Karlova EV. Prospects and therapeutic strategies in the management of dry eye disease: a review. Ophthalmology Reports. 2026;19(2):83-93. doi:10.17816/ov696065

BibTeX
@article{Fedorova2026,
  author = {Fedorova, Irina A. and Zolotarev, Andrey V. and Kiseleva, Olga A. and Karlova, Elena V.},
  title = {Prospects and therapeutic strategies in the management of dry eye disease: a review},
  journal = {Ophthalmology Reports},
  year = {2026},
  volume = {19},
  number = {2},
  pages = {83--93},
  doi = {10.17816/ov696065}
}
Kostenlos starten →